Xtant Medical Holdings XTNT Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Product | ||||||
| Orthobiologics | $15.61M-14.7% | $18.3M+6.7% | $17.15M-11.5% | $19.37M+7.2% | $18.07M-1.2% | |
| Spinal Implant | $5.28M-44.0% | $9.41M-11.4% | $10.62M-4.0% | $11.07M-1.3% | $11.21M-4.3% | |
| Percentage Of Net Revenue by Product | ||||||
| Orthobiologics | 75%— | —— | 52%-3.0pp | 55%0.0pp | 55%+54.0pp | |
| Spinal Implant | 25%— | —— | 32%+1.0pp | 31%-3.0pp | 34%— | |
| Revenue by Geography | ||||||
| Non Us | $177K-92.8% | $2.47M-16.1% | $2.94M-10.2% | $3.28M+17.7% | $2.79M+1.5% | |
| US | $20.71M-30.7% | $29.89M-1.4% | $30.31M-5.7% | $32.13M+6.7% | $30.12M+4.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Xtant Medical Holdings break its business down?
- Xtant Medical Holdings (XTNT) reports revenue by product across 2 parts — Orthobiologics and Spinal Implant. Each is extracted from the segment footnotes and tracked over time.
- Where does Xtant Medical Holdings's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Xtant Medical Holdings's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
